canine mammary tumours

send to a friend share this

VEGFR-2: a potential therapeutic target for canine mammary tumours

Researchers from the Institute of Biomedical Sciences Abel Salazar of the University of Porto, found that VEGFR-2, the major receptor activated by VEGF during angiogenesis, is highly expressed in canine mammary gland carcinosarcomas, a rare tumour type of canine and human breast. This finding reinforces the role of spontaneous canine mammary tumours as a model to study uncommon types of women breast cancer.

 

Authors and Affiliations:

Santos, A.1, Lopes, C.2, Gärtner, F.2,3, Matos, A.J.F.4,5

Tumor cells present a dynamic expression of galectins during metastasis

A group of researchers from IPATIMUP found that the differential expression of galectin-1 and galectin-3 participates in the process of metastasis in a spontaneous canine model of breast cancer.

 

Authors and Affiliations:

Joana T. de Oliveira1,2,3, Augusto J. de Matos2, Rita Barros1, Cláudia Ribeiro1, Asaf Chen1, Venceslau Hespanhol4, Gerard R Rutteman5,6 and Fátima Gärtner1,2